NCT00042341 2022-05-27
Phase II Study of Clofarabine in Pediatric Acute Lymphoblastic Leukemia (ALL)
Sanofi
Phase 2 Completed
Clinical Trials
14 trialsNCT01031368 2019-03-01
Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia
Nohla Therapeutics, Inc.
Phase 1 Completed
NCT02544789 2015-09-09
Clofarabine in Chinese Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia
Betta Pharmaceuticals Co., Ltd.
Phase 2 Completed
NCT00991133 2015-04-30
A Safety and Tolerability Study of Clofarabine, Etoposide, Cyclophosphamide, PEG-asparaginase, and Vincristine in Pediatric Acute Lymphoblastic Leukemia (ALL)
Sanofi
Phase 1 Completed
NCT00042354 2015-03-05
Phase II Study of Clofarabine in Pediatric Acute Myelogenous Leukemia (AML) Patients
Sanofi
Phase 2 Completed
NCT00315705 2014-04-14
A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias.
Sanofi
Phase 1/2 Completed
NCT00317642 2014-04-14
A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I)
Sanofi
Phase 3 Completed
NCT00373529 2014-04-14
A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II)
Sanofi
Phase 2 Completed
NCT00044889 2014-03-19
Phase II Study of Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia
Sanofi
Phase 2 Completed
NCT00125827 2014-03-19
Study of Oral Clofarabine Administered Daily for 5 Days in Adult Patients With Refractory Solid Tumors
Sanofi
Phase 1 Completed
NCT01090167 2014-03-19
A Study of Clofarabine in Japanese Patients With Acute Myeloid Leukemia (AML)
Sanofi
Phase 1 Completed
NCT01196013 2014-03-19
A Study of Clofarabine in Japanese Paediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukaemia
Sanofi
Phase 1 Completed
NCT00930098 2014-02-11
A Phase II, Open-Label Study of Clofarabine in Paediatric Patients With Refractory/Relapsed Acute Lymphoblastic Leukaemia
Sanofi
Phase 2 Completed
NCT00125840 2014-02-05
Clofarabine in Adult Patients With Advanced Solid Tumors
Sanofi
Phase 1 Completed